Press Releases Items Per Page 102550 Year None202220212020201920182017201620152012 Aug 09, 2022 Galera Reports Second Quarter 2022 Financial Results and Recent Corporate Updates View HTML PDF Version Jun 29, 2022 Galera Announces Results from Phase 1 Stage of GRECO-1 Trial of Rucosopasem with SBRT for NSCLC View HTML PDF Version Jun 02, 2022 Galera to Present at Jefferies Healthcare Conference View HTML PDF Version May 26, 2022 Galera Announces Oral Presentation at 2022 American Society of Clinical Oncology (ASCO) Annual Meeting Detailing Results from Phase 3 ROMAN Trial of Avasopasem View HTML PDF Version May 16, 2022 Galera Reports First Quarter 2022 Financial Results and Recent Corporate Updates View HTML PDF Version May 16, 2022 Galera Announces Plan to Submit Avasopasem NDA by Year End View HTML PDF Version May 02, 2022 Galera Announces Topline Results from Phase 2a AESOP Trial of Avasopasem for Chemoradiotherapy-Induced Esophagitis View HTML PDF Version Apr 27, 2022 Galera to Present at 2022 American Society of Clinical Oncology (ASCO) Annual Meeting View HTML PDF Version Mar 10, 2022 Galera Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Corporate Updates View HTML PDF Version Jan 06, 2022 Galera to Present at H.C. Wainwright BioConnect Conference View HTML PDF Version results
